SHOULDER INNOVATIONS, INC.(SI)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

SHOULDER INNOVATIONS, INC. (SI) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SI at 29.5/100 on a 32-signal composite quality model, placing it at rank #2,529 of 2,961 stocks — the bottom half of the AI-ranked universe. SI scores in the top quartile across revenue growth (86.4). Areas of concern include free cash flow (7.3) and balance sheet strength (7.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 39.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), SHOULDER INNOVATIONS, INC. reports quarterly revenue of $17.2M, net income of $-10.2M, an operating margin of -58.4%. Top institutional holders of SI by reported 13-F value include FMR, BlackRock, SECTORAL ASSET MANAGEMENT, based on the most recent SEC filings. SI trades on the NYSE exchange and files with the SEC under CIK 1699350. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for SHOULDER INNOVATIONS, INC. directly from SEC EDGAR.